CLASS II Drug recall · Reported 27 Jul 2016 · FDA Enforcement Report
Bactroban Cream, (Mupirocin Calcium Cream 2%) tube recalled
GlaxoSmithKline is recalling Bactroban Cream, (Mupirocin Calcium Cream 2%) tube, distributed nationwide in the US. The recall was initiated on 18 Jul 2016 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-1442-2016
- FDA event ID
- 74742
- Recalling firm
- GlaxoSmithKline, Zebulon, NC
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 18 Jul 2016
- FDA classified
- 20 Jul 2016
- Reported
- 27 Jul 2016
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Other Reasons
- Drug class
- Creams, Ointments & Gels
Timeline
| 18 Jul 2016 | Recall initiated by company | |
| 20 Jul 2016 | Classified by FDA | +2 days |
| 27 Jul 2016 | Published in enforcement report | +7 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Penicillin Cross Contamination
Product as listed by the FDA
Bactroban Cream, (Mupirocin Calcium Cream 2%), 15 gram tube, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709, Made in England, NDC 0029-1527-22,
Where it was distributed
Nationwide and PR.
Questions about this recall
Why was it recalled?
Penicillin Cross Contamination
Which lots are affected?
Lot #: C725860, Exp. Nov 2016; C740904, Exp. Feb 2017.
Where was it sold?
Nationwide and PR.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
3 other products · FDA event 74742| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| CLASS II | Bactroban Ointment, (Mupirocin Ointment 2%) tube recalled | GlaxoSmithKline | Other | Nationwide | |
| CLASS II | Bactroban Nasal, (Mupirocin Calcium Ointment 2%) Single Use Tubes recalled | GlaxoSmithKline | Other | Nationwide | |
| CLASS II | Bactroban Cream, (Mupirocin Calcium Cream 2%) tube recalled | GlaxoSmithKline | Other | Nationwide |
More recalls from GlaxoSmithKline
All 23| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension recalledTivicay | GlaxoSmithKline | Other | Nationwide |
| Drug | CLASS III | Anoro Ellipta (umeclidinium recalled by GlaxoSmithKlineAnoro Ellipta | GlaxoSmithKline | Potency & Assay | Nationwide |
| Drug | CLASS III | Tivicay (dolutegravir) Tablets 50 mg recalled by GlaxoSmithKlineTivicay | GlaxoSmithKline | Other | Nationwide |
| Drug | CLASS II | Ventolin HFA (albuterol sulfate) Inhalation recalled by GlaxoSmithKlineVentolin | GlaxoSmithKline | Potency & Assay | Nationwide |
| Drug | CLASS II | Ventolin HFA (albuterol sulfate) Inhalation Aerosol recalledVentolin | GlaxoSmithKline | Potency & Assay | Nationwide |
Other Bactroban recalls
All 4| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Bactroban Cream, (Mupirocin Calcium Cream 2%) tube recalled | GlaxoSmithKline | Other | Nationwide |
| Drug | CLASS II | Bactroban Nasal, (Mupirocin Calcium Ointment 2%) Single Use Tubes recalled | GlaxoSmithKline | Other | Nationwide |
| Drug | CLASS II | Bactroban Ointment, (Mupirocin Ointment 2%) tube recalled | GlaxoSmithKline | Other | Nationwide |